KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs-Reference-Cited by-同舟云学术

KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs

Published:2013-01-16 Issue: Volume: Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Tzatsos Alexandros,Paskaleva Polina,Ferrari Francesco,Deshpande Vikram,Stoykova Svetlana,Contino Gianmarco,Wong Kwok-Kin,Lan Fei,Trojer Patrick,Park Peter J.,Bardeesy Nabeel

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Pancreatic Cancer

2. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

3. A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival

4. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

5. Cancer epigenetics reaches mainstream oncology

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy;Autoimmunity Reviews;2024-06

2. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma;Cell Death Discovery;2024-05-24

3. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex;International Journal of Molecular Sciences;2024-05-07

4. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4;Metabolism;2024-01

5. Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype;Science Advances;2023-11-24